Literature DB >> 21654731

Mosaics and moles.

Lone Sunde1, Isa Niemann, Estrid Staehr Hansen, Johnny Hindkjaer, Birte Degn, Uffe Birk Jensen, Lars Bolund.   

Abstract

Hydatidiform mole (HM) is an abnormal human pregnancy, where the placenta presents with vesicular swelling of the chorionic villi. A fetus is either not present, or malformed and not viable. Most moles are diploid androgenetic as if one spermatozoon fertilized an empty oocyte, or triploid with one maternal and two paternal chromosome sets as if two spermatozoa fertilized a normal oocyte. However, diploid moles with both paternal and maternal markers of the nuclear genome have been reported. Among 162 consecutively collected diploid moles, we have earlier found indications of both maternal and paternal genomes in 11. In the present study, we have performed detailed analysis of DNA-markers in tissue and single cells from these 11 HMs. In 3/11, we identified one biparental cell population only, whereas in 8/11, we demonstrated mosaicism: one biparental cell population and one androgenetic cell population. One mosaic mole was followed by persistent trophoblastic disease (PTD). In seven of the mosaics, one spermatozoon appeared to have contributed to the genomes of both cell types. Our observations make it likely that mosaic conceptuses, encompassing an androgenetic cell population, result from various postzygotic abnormalities, including paternal pronuclear duplication, asymmetric cytokinesis, and postzygotic diploidization. This corroborates the suggestion that fertilization of an empty egg is not mandatory for the creation of an androgenetic cell population. Future studies of mosaic conceptuses may disclose details about fertilization, early cell divisions and differentiation. Apparently, only a minority of diploid moles with both paternal and maternal markers are 'genuine' diploid biparental moles (DiBiparHMs).

Entities:  

Mesh:

Year:  2011        PMID: 21654731      PMCID: PMC3190256          DOI: 10.1038/ejhg.2011.93

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  35 in total

Review 1.  The genetics of hydatidiform moles: new lights on an ancient disease.

Authors:  R Slim; A Mehio
Journal:  Clin Genet       Date:  2007-01       Impact factor: 4.438

2.  A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles.

Authors:  Y C Kou; L Shao; H H Peng; R Rosetta; D del Gaudio; A F Wagner; T K Al-Hussaini; I B Van den Veyver
Journal:  Mol Hum Reprod       Date:  2007-11-26       Impact factor: 4.025

3.  Twin pregnancies with diploid hydatidiform mole and co-existing normal fetus may originate from one oocyte.

Authors:  Isa Niemann; Lars Bolund; Lone Sunde
Journal:  Hum Reprod       Date:  2008-06-12       Impact factor: 6.918

4.  The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.

Authors:  Isa Niemann; Estrid S Hansen; Lone Sunde
Journal:  Gynecol Oncol       Date:  2006-10-02       Impact factor: 5.482

5.  Reproductive consequences of genome-wide paternal uniparental disomy mosaicism: description of two cases with different mechanisms of origin and pregnancy outcomes.

Authors:  Carme Morales; Anna Soler; Cèlia Badenas; Laia Rodríguez-Revenga; Alfons Nadal; José M Martínez; Irene Mademont-Soler; Antoni Borrell; Montserrat Milà; Aurora Sánchez
Journal:  Fertil Steril       Date:  2009-05-13       Impact factor: 7.329

6.  Placental mesenchymal dysplasia with beckwith-wiedemann syndrome fetus in the context of biparental and androgenic cell lines.

Authors:  D H'mida; M Gribaa; T Yacoubi; A Chaieb; L Adala; H Elghezal; A Saad
Journal:  Placenta       Date:  2008-03-17       Impact factor: 3.481

7.  The clinical phenotype of mosaicism for genome-wide paternal uniparental disomy: two new reports.

Authors:  Meredith Wilson; Gregory Peters; Bruce Bennetts; George McGillivray; Zan He Wu; Christopher Poon; Elizabeth Algar
Journal:  Am J Med Genet A       Date:  2008-01-15       Impact factor: 2.802

8.  P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions.

Authors:  Lori Hoffner; Jeanette Dunn; Nicole Esposito; Trevor Macpherson; Urvashi Surti
Journal:  Hum Pathol       Date:  2007-10-01       Impact factor: 3.466

9.  Androgenetic/biparental mosaicism in an infant with hepatic mesenchymal hamartoma and placental mesenchymal dysplasia.

Authors:  Robyn C Reed; Linda Beischel; Jonathan Schoof; John Johnson; Michael L Raff; Raj P Kapur
Journal:  Pediatr Dev Pathol       Date:  2008-02-08

10.  Genetic and epigenetic analysis of recurrent hydatidiform mole.

Authors:  Bruce E Hayward; Michel De Vos; Nargese Talati; M Reza Abdollahi; Graham R Taylor; Esther Meyer; Denise Williams; Eamonn R Maher; Faridon Setna; Kausar Nazir; Shahnaz Hussaini; Hussain Jafri; Yasmin Rashid; Eamonn Sheridan; David T Bonthron
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

View more
  10 in total

1.  Cell-free DNA in pregnancy with choriocarcinoma and coexistent live fetus: A case report.

Authors:  Mona Kjaerboel Kristiansen; Isa Niemann; Jacob Christian Lindegaard; Mette Christiansen; Mette Warming Joergensen; Ida Vogel; Dorte Launholt Lildballe; Lone Sunde
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

2.  Early Fertilization Abnormalities in the Human: An Exhausted Area of Research?

Authors:  Bernd Rosenbusch
Journal:  J Reprod Infertil       Date:  2017 Oct-Dec

3.  Genome-wide single nucleotide polymorphism array analysis unveils the origin of heterozygous androgenetic complete moles.

Authors:  Hirokazu Usui; Kazuhiko Nakabayashi; Kayoko Maehara; Kenichiro Hata; Makio Shozu
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

4.  Molecular cytogenetic analysis of a hydatidiform mole with coexistent fetus: a case report.

Authors:  Nozomi Uemura; Yasushi Takai; Yukiko Mikami; Miwa Ogasawara; Masahiro Saitoh; Kazunori Baba; Junichi Tamaru; Masaaki Hara; Hiroyuki Seki
Journal:  J Med Case Rep       Date:  2019-08-18

5.  p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types.

Authors:  Helle Lund; Søren Nielsen; Anni Grove; Mogens Vyberg; Lone Sunde
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-10

6.  Hydatidiform mole diagnostics using circulating gestational trophoblasts isolated from maternal blood.

Authors:  Lone Sunde; Ripudaman Singh; Katarina Ravn; Palle Schelde; Estrid Staehr Hansen; Niels Uldbjerg; Isa Niemann; Lotte Hatt
Journal:  Mol Genet Genomic Med       Date:  2020-12-11       Impact factor: 2.183

7.  Parental genomes segregate into distinct blastomeres during multipolar zygotic divisions leading to mixoploid and chimeric blastocysts.

Authors:  Tine De Coster; Heleen Masset; Olga Tšuiko; Maaike Catteeuw; Yan Zhao; Nicolas Dierckxsens; Ainhoa Larreategui Aparicio; Eftychia Dimitriadou; Sophie Debrock; Karen Peeraer; Marta de Ruijter-Villani; Katrien Smits; Ann Van Soom; Joris Robert Vermeesch
Journal:  Genome Biol       Date:  2022-10-03       Impact factor: 17.906

8.  Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.

Authors:  Deyin Xing; Emily Adams; Jialing Huang; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

9.  Triploidy--Observations in 154 Diandric Cases.

Authors:  Nanna Brink Scholz; Lars Bolund; Mette Nyegaard; Louise Faaborg; Mette Warming Jørgensen; Helle Lund; Isa Niemann; Lone Sunde
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

10.  Paternal Hemizygosity in 11p15 in Mole-like Conceptuses: Two Case Reports.

Authors:  Lone Sunde; Helle Lund; Neil J Sebire; Anni Grove; Rosemary A Fisher; Isa Niemann; Eigil Kjeldsen; Lotte Andreasen; Estrid Staehr Hansen; Anders Bojesen; Lars Bolund; Mette Nyegaard
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.